Yijun Huang, PhD
About Yijun Huang, PhD
Yijun Huang, PhD, serves as the Associate Director of Cell & Gene Therapy Testing at Ocugen, where he has worked since 2022. He has a strong background in biopharmaceutical testing, quality control, and the development of novel therapeutics, with previous roles at WuXi AppTec and WuXi Advanced Therapies.
Work at Ocugen
Yijun Huang has been serving as the Associate Director of Cell & Gene Therapy Testing at Ocugen since 2022. In this role, he is responsible for overseeing testing processes related to cell and gene therapies, ensuring compliance with industry standards and regulatory requirements. His position involves leading teams in assay development and validation, focusing on the quality control of biologics and gene therapies. Huang's expertise is instrumental in advancing Ocugen's initiatives in the biopharmaceutical sector.
Previous Experience at WuXi AppTec
Prior to his current role, Yijun Huang worked at WuXi AppTec as a Senior Scientist from 2013 to 2017. During his four years there, he specialized in Quality Control and Technical Development. His contributions included developing and implementing quality control measures that ensured the integrity and reliability of biopharmaceutical products.
Experience at WuXi Advanced Therapies
Yijun Huang continued his career at WuXi Advanced Therapies, where he served as a Scientific Fellow in Analytical Development from 2017 to 2022. In this five-year tenure, he focused on the analytical aspects of therapeutic development, contributing to the advancement of methodologies and practices in the field of cell and gene therapy.
Education and Expertise
Yijun Huang earned his PhD in Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy, where he studied from 2008 to 2011. His academic background includes extensive research in drug discovery, particularly during his time as a Graduate Researcher at the University of Pittsburgh's Drug Discovery Institute. Additionally, he completed a Postdoctoral Research Fellowship at the University of Pennsylvania in the Department of Pathology & Laboratory Medicine from 2012 to 2013. Huang possesses significant expertise in assay development and validation, particularly in biopharmaceutical testing.
Contributions to Cell and Gene Therapy
Yijun Huang has made significant contributions to the discovery and development of novel therapeutics, particularly in the field of cell and gene therapy. His extensive experience in assay development and validation has positioned him as a key player in advancing methodologies that support the quality control of biologics and gene therapies. His work has implications for improving therapeutic outcomes in patients.